Update on drug transporter proteins in acute myeloid leukemia: Pathological implication and clinical setting

2021 ◽  
Vol 160 ◽  
pp. 103281
Author(s):  
Flavia Cunha Vasconcelos ◽  
Paloma Silva de Souza ◽  
Thaís Hancio ◽  
Fernanda Costas Casal de Faria ◽  
Raquel Ciuvalschi Maia
Keyword(s):  
Acute Myeloid Leukemia ◽  
Clinical Setting ◽  
Myeloid Leukemia ◽  
Drug Transporter ◽  
Transporter Proteins ◽  
Acute Myeloid

scholarly journals Management of Duodenal Atresia in the setting of Congenital Leukemia with Massive Hepatomegaly

2013 ◽  
Vol 2 (3) ◽  
pp. 32
Author(s):  
Sathyaprasad C Burjonrappa
Keyword(s):  
Acute Myeloid Leukemia ◽  
Surgical Management ◽  
Clinical Setting ◽  
Trisomy 21 ◽  
Myeloid Leukemia ◽  
Duodenal Atresia ◽  
Myeloproliferative Disorder ◽  
Technical Aspects ◽  
Congenital Leukemia ◽  
Acute Myeloid

Down's syndrome (DS) is associated with duodenal atresia (DA) in about 8-10% of cases. Transient Myeloproliferative Disorder (TMD)/Acute Myeloid Leukemia (AML) is also associated with the trisomy 21 mutation. The occurrence of the two conditions together complicates the diagnosis and surgical management of the DA. We discuss the technical aspects of management of the DA in this clinical setting.

scholarly journals Overexpression of the ABCB1 drug transporter in acute myeloid leukemia cells is associated with downregulation of latrophilin-1

2018 ◽  
Vol 37 (03) ◽  
pp. 353-357 ◽  
Author(s):  
Zuzana Kocibalova ◽  
Martina Guzyova ◽  
Denisa Imrichova ◽  
Zdena Sulova ◽  
Albert Breier
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Leukemia Cells ◽  
Drug Transporter ◽  
Acute Myeloid Leukemia Cells ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document